Abstract:
:A proportion of familial breast cancer has recently been shown by genetic linkage analysis to map to chromosome l3q12 (Wooster et al, 1994). This locus contains a tumor suppressor gene BRCA2, mutations in which lead to tumorigenesis. Genetic alterations at this locus have also been shown in pancreatic adenocarcinoma and in hepatocellular carcinoma. In an effort to isolate the BRCA2 gene, we have cloned 73 non overlapping cDNAs from a set of nine YACs spanning 6 cM interval on chromosome 13q12 by using a direct cDNA selection method. One of the selected cDNAs corresponds to a region of the 3' portion of BRCA2 mRNA, the sequence of which was published recently (Wooster et al, 1995). Northern analysis of BRCA2 transcripts from a variety of cell lines showed altered sizes of the mRNA in a breast cancer cell line (MCF7) and a prostate carcinoma cell line (DU145). Furthermore, BRCA2 transcript was present in cDNA libraries from total fetus as well as adult human tissues. Fifteen unique cDNA fragments encode genes/ESTs that are already known, of which only two have been mapped to this region. The other 12 cDNAs include genes for RPL6/mRNA for TAX REB 107, elongation factor-1 delta, 26S protease S4 regulatory subunit, small cytoplasmic 7SL RNA, a full length open reading frame (ORFU), brain thiol specific antioxidant protein, ribosomal protein, L35, and lipoxygenase activating protein. Six cDNAs represent human homologs of genes known in other species, namely, mouse HSPE71, Rat RhoGAP protein, S cerevisiae leucyl tRNA synthetase and S cerevisiae chromosome II ORF YBLO44W. The remaining 52 cDNAs showed either weak similarity or no similarity to sequences in the nucleotide data base and hence would represent novel genes. The plausible functions of some of these genes based on their sequence similarity to other known genes is discussed.
journal_name
Oncogenejournal_title
Oncogeneauthors
Jacob AN,Kandpal G,Kandpal RPsubject
Has Abstractpub_date
1996-07-04 00:00:00pages
213-21issue
1eissn
0950-9232issn
1476-5594journal_volume
13pub_type
相关文献
ONCOGENE文献大全abstract::Ectopic expression of metabotropic glutamate receptor subtype 1 (mGluR1) in mouse melanocytes induces melanoma formation. Although requirement of mGluR1 for development of melanoma in the initial stage has been demonstrated, its role in melanoma growth in vivo remains unclear. In this study, we developed novel transge...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2008.329
更新日期:2008-12-04 00:00:00
abstract::Sex-determining region Y box 6 (SOX6) has been described as a tumor-suppressor gene in several cancers. Our previous work has suggested that SOX6 upregulated p21(Waf1/Cip1)(p21) expression in a p53-dependent manner; however, the underlying mechanism has remained elusive. In this study, we confirmed that SOX6 can suppr...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2015.234
更新日期:2016-03-31 00:00:00
abstract::We analysed the involvement of proteases during taxol-mediated cell death of human A549 non-small-cell lung carcinoma cells using a proteomics approach that specifically targets protein N termini and further detects newly formed N termini that are the result of protein processing. Our analysis revealed 27 protease-med...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2008.96
更新日期:2008-07-31 00:00:00
abstract::Alu sequences are the most abundant short interspersed repeated elements in the human genome. Here we show that in a cell culture model of colorectal cancer (CRC) progression, we observe accumulation of Alu RNA that is associated with reduced DICER1 levels. Alu RNA induces epithelial-to-mesenchymal transition (EMT) by...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2017.369
更新日期:2018-02-01 00:00:00
abstract::Despite the fact that objective response rates to 5-FU are as low as 20%, 5-FU remains the most commonly used drug for the treatment of colorectal cancer. The lack of understanding of resistance to 5-FU, therefore, remains a significant impediment in maximizing its efficacy. We used intestinal epithelial cells with an...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1208552
更新日期:2005-06-02 00:00:00
abstract::The growth and dissemination of tumors rely on an altered vascular network, which supports their survival and expansion and provides accessibility to the vasculature and a route of transport for metastasizing tumor cells. The remodeling of vascular structures through generation of new vessels (for example, via tumor a...
journal_title:Oncogene
pub_type: 杂志文章,评审
doi:10.1038/onc.2013.304
更新日期:2014-07-03 00:00:00
abstract::Zebrafish are making big waves in the field of cancer research. The effect has been widespread and continues to gain speed as more and more cancer researchers ride the wave of zebrafish biology. This has been largely due to the development of transgenic and xenograft models of cancer, which recapitulate many aspects o...
journal_title:Oncogene
pub_type: 杂志文章,评审
doi:10.1038/onc.2008.95
更新日期:2008-07-31 00:00:00
abstract::Hepatitis B virus (HBV) infection is a major risk factor worldwide for the development of hepatocellular carcinoma (HCC). Integrated HBV DNA fragments, often highly rearranged, are frequently detected in HCC. In woodchuck, the viral enhancer plays a central role in hepatocarcinogenesis, but in humans the mechanism of ...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1204879
更新日期:2001-10-18 00:00:00
abstract::Resistance and relapse are still primary causes that result in poor effectiveness of chemotherapy in malignant gliomas. Therefore, development of new therapeutic strategies requires the identification of key molecular pathways regulating chemoresistance. We previously found that abnormal high expression of the Tie2 re...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2009.103
更新日期:2009-06-18 00:00:00
abstract::The retinoblastoma (Rb) tumor suppressor gene and its close relatives p107 and p130 are best known for their function in the control of cell cycle progression. In recent years, however, a new role for these proteins has been emerging as they have been linked with regulation of terminal differentiation of many tissues ...
journal_title:Oncogene
pub_type: 杂志文章,评审
doi:10.1038/sj.onc.1203244
更新日期:1999-12-20 00:00:00
abstract::L-ascorbate (L-ascorbic acid, vitamin C) clearly has an inhibitory effect on cancer cells. However, the mechanism underlying differential sensitivity of cancer cells from same tissue to L-ascorbate is yet to be clarified. Here, we demonstrate that L-ascorbate has a selective killing effect, which is influenced by sodi...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2012.176
更新日期:2013-03-21 00:00:00
abstract::Expression of constitutively activated M-Ras in normal murine bone-marrow cells was sufficient to induce the factor-independent, in vitro growth and differentiation of colonies of macrophages and neutrophils, and the generation of immortal lines of factor-independent mast cells, and, upon in vivo injection of the tran...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1208441
更新日期:2005-03-31 00:00:00
abstract::Antioxidant response element (ARE)-mediated expression and coordinated induction of genes encoding detoxifying enzymes is one mechanism of critical importance to cellular protection against oxidative stress. In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Ju...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1202237
更新日期:1998-12-17 00:00:00
abstract::Loss of heterozygosity on chromosome 10p was observed frequently in human prostate cancers. Studies have demonstrated that the introduction of the short arm of human chromosome 10 into a human prostate cancer cell line, PPC-1, by microcell-mediated chromosome transfer (MMCT), suppressed the malignant phenotype, sugges...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1204079
更新日期:2001-01-18 00:00:00
abstract::Germline mutations in the tumor suppressor BRCA1 predispose women to breast and ovarian cancers. Current evidence demonstrates that mutations in BRCA1 do not directly result in tumor formation, but instead cause genetic instability, subjecting cells to high risks of malignant transformation. In an animal model in whic...
journal_title:Oncogene
pub_type: 杂志文章,评审
doi:10.1038/sj.onc.1203269
更新日期:2000-02-21 00:00:00
abstract::Constitutive activation of the signal transducer and activator of transcription 3 (Stat3) and mutation of the p53 are both commonly detected in human prostate cancer cells. We sought to investigate whether there is functional regulation of Stat3 by wild-type (wt) p53. Our results demonstrate that expression of wt p53 ...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1205426
更新日期:2002-05-02 00:00:00
abstract::The antifolates were the first class of antimetabolites to enter the clinics more than 50 years ago. Over the following decades, a full understanding of their mechanisms of action and chemotherapeutic potential evolved along with the mechanisms by which cells develop resistance to these drugs. These principals served ...
journal_title:Oncogene
pub_type: 杂志文章,评审
doi:10.1038/sj.onc.1206946
更新日期:2003-10-20 00:00:00
abstract::Long-lived species Homo sapiens have evolved robust protection mechanisms against cancer by repressing telomerase and maintaining short telomeres, thereby delaying the onset of the majority of cancer types until post-reproductive age. Indeed, telomerase is silent in most differentiated human cells, predominantly due t...
journal_title:Oncogene
pub_type: 杂志文章,评审
doi:10.1038/s41388-019-0872-9
更新日期:2019-08-01 00:00:00
abstract::Epstein-Barr virus (EBV) encoded latent membrane protein 1 (LMP1) is noted for its transforming potential. Yet, it also acts as a cytostatic and growth-relenting factor in Burkitt's lymphoma (BL) cells. The underlying molecular mechanisms of the growth inhibitory property of LMP1 have remained largely unknown. In this...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2009.439
更新日期:2010-03-04 00:00:00
abstract::We isolated three related cDNA clones from a mouse cerebellar library; the type I cDNA was identical to the gene encoding the apoptosis-associated tyrosine kinase (AATYK), whose expression in myeloid precursor cells is increased during growth arrest or apoptosis. Low levels of AATYK mRNA expression were seen in adult ...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1204210
更新日期:2001-03-01 00:00:00
abstract::Ovarian endometrioid adenocarcinomas (OEAs) frequently exhibit constitutive activation of canonical WNT signaling, usually as a result of oncogenic mutations that stabilize and dysregulate the β-catenin protein. In previous work, we used microarray-based methods to compare gene expression in OEAs with and without dysr...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2011.123
更新日期:2011-10-06 00:00:00
abstract::The majority (75%) of human breast cancers express estrogen receptor (ER). Although ER-positive tumors usually respond to antiestrogen therapies, 30% of them do not. It is not known what controls the ER status of breast cancers or their responsiveness to antihormone interventions. In this report, we document that tran...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1208597
更新日期:2005-06-16 00:00:00
abstract::Chromatin remodeling proteins regulate multiple aspects of cell homeostasis, making them ideal candidates for misregulation in transformed cells. Here, we explore Sin3A, a member of the Sin3 family of proteins linked to tumorigenesis that are thought to regulate gene expression through their role as histone deacetylas...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2012.326
更新日期:2013-06-27 00:00:00
abstract::Acquired therapeutic resistance is the major drawback to effective systemic therapies for cancers. Aggressive triple-negative breast cancers (TNBC) develop resistance to chemotherapies rapidly, whereas the underlying mechanisms are not completely understood. Here we show that genotoxic treatments significantly increas...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2015.189
更新日期:2016-03-10 00:00:00
abstract::Transactivating proteins associated with complex onco-retroviruses including human T-cell leukemia virus-1 (HTLV-1) and bovine leukemia virus (BLV) mediate transformation using poorly understood mechanisms. To gain insight into the processes that govern tumor onset and progression, we have examined the impact of BLV-T...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1206546
更新日期:2003-07-17 00:00:00
abstract::Estrogen receptor-alpha (ERalpha) and its ligand estradiol (E2) has critical roles in breast cancer growth and are key therapeutic targets. In this study, we report a novel dual role of the adenosine A1 receptor (Adora1) as an E2/ERalpha target and a regulator of ERalpha transcriptional activity. In ERalpha-positive b...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2009.409
更新日期:2010-02-25 00:00:00
abstract::This issue attempts to give a 'state of the art' overview of the AP-1 transcription factor family, a fundamental class of transcriptional regulators. The AP-1 family consists of several bZIP (basic region leucine zipper) domain proteins, the Jun, the Fos, and the ATF subfamilies, which all have to dimerize before they...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1204416
更新日期:2001-04-30 00:00:00
abstract::Although increasing evidence indicated that the deregulation of microRNAs (miRNAs) contributes to tumorigenesis and invasion, little is known about the role of miR-637 in human gliomas. In the present study, we found that the expression level of miR-637 was significantly reduced in clinical glioma tissues compared wit...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2014.419
更新日期:2015-09-17 00:00:00
abstract::The phosphatidylinositol 3' kinase (PI3K) pathway is involved in many cellular processes including cell proliferation, survival and glucose transport, and is implicated in various disease states, such as cancer and diabetes. Although there have been numerous studies dissecting the role of PI3K signaling in different c...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/onc.2013.44
更新日期:2013-11-21 00:00:00
abstract::The p53 tumor suppressor is regulated by the MDM2 oncoprotein. Overexpression of MDM2 maintains p53 at low levels and contributes to the functional inactivation of p53 in a subset of tumors. We found that treatment with roscovitine and olomoucin, which were originally developed as cyclin-dependent kinase (CDK) inhibit...
journal_title:Oncogene
pub_type: 杂志文章
doi:10.1038/sj.onc.1204412
更新日期:2001-05-31 00:00:00